New reforms recently announced by the MHRA include a commitment to introduce a 14‑day initial assessment pathway for #PhaseI trials, strengthening the UK’s position as a leading destination for early‑phase clinical research. Read the full press release here: bit.ly/4kqhjbf
First-in-class neurodegeneration drug nears Phase I, signaling renewed momentum in longevity-focused neuroscience.
longevity.technology/news/lysoway...
#longevity #neuroscience #brainhealth #PhaseI #cellularhealth #biotech #neurodegeneration
Drug metabolism modifies drugs via Phase I and II liver reactions to aid detoxification and excretion. #DrugMetabolism #CytochromeP450 #Pharmacokinetics #PhaseI #PhaseII #Pharmacology #Liver #DrugExcretion #MedicalEducation #USMLE
Drs. Viviane Tabar, Lorenz Studer, & Claire Henchcliffe completed a #PhaseI trial confirming safety of an hESC-derived therapy for #Parkinsons!
Read their paper: go.nature.com/44Oyspk
Learn more in this episode recorded at BlueRock Therapeutics: bit.ly/42TiW92
📢 It has been a learning experience over the past 3 days at #ESMOTAT25 to listen to experts in the field of #phaseI #drugdevelopment
🗣️ The talks were truly insightful
✅ New and improved drugs 🎯
📊 Innovative trial designs
@myesmo.bsky.social
@viveksubbiah.bsky.social
@oncoalert.bsky.social
#MBBS #PhaseI
GMC guidance brought to life
Test your knowledge of our ethical guidance by visiting Good medical practice in action. You get to choose what the doctor should do in over 60 scenarios.
#MBBS #PhaseI
Design, applications, strengths and weaknesses of cross-sectional, analytical studies, and intervention studies